Home/Filings/4/0001415889-22-005317
4//SEC Filing

Calabrese Salvatore 4

Accession 0001415889-22-005317

CIK 0001819411other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 5:00 PM ET

Size

4.5 KB

Accession

0001415889-22-005317

Insider Transaction Report

Form 4
Period: 2022-05-19
Calabrese Salvatore
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2022-05-19$8100.00/sh+3,000$24,300,000

Issuer

Gain Therapeutics, Inc.

CIK 0001819411

Entity typeother

Related Parties

1
  • filerCIK 0001851958

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:00 PM ET
Size
4.5 KB